Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alyssa Pittman"'
Autor:
Gwynn D. Long, Sendhilnathan Ramalingam, Nelson J. Chao, Cristina Gasparetto, Lauren Bohannon, Keith M. Sullivan, Patrick Smith, Yen P. Lowder, Taewoong Choi, Alexandra Artica, Meagan Lew, Anthony D. Sung, David A. Rizzieri, Stefanie Sarantopoulos, Richard D. Lopez, Alyssa Pittman, Mitchell E. Horwitz, Jillian C. Thompson, Kristi Romero
Publikováno v:
Bone Marrow Transplantation. 57:89-94
Hematopoietic cell transplant (HCT) is an increasingly common and curative treatment strategy to improve survival among individuals with malignant and nonmalignant diseases, with over one million HCTs having been performed worldwide. Neurocognitive d
Autor:
Meagan V. Lew, Yi Ren, Yen P. Lowder, Sharareh Siamakpour-Reihani, Sendhilnathan Ramalingam, Kristi M. Romero, Jillian C. Thompson, Lauren M. Bohannon, Jackie McIntyre, Helen Tang, Jolien Van Opstal, Ernaya Johnson, Harvey Jay Cohen, David B. Bartlett, Amy M. Pastva, Miriam Morey, Katherine S. Hall, Patrick Smith, Katherine B. Peters, Tamara J. Somers, Sarah Kelleher, Sophia K. Smith, Paul E. Wischmeyer, Pao-Hwa Lin, William A. Wood, Glynnis Thorpe, Kerry Minor, Kristi Wiggins, Therese Hennig, Tanya Helms, Renee Welch, Brittany Matthews, JoAnn Liu, Jill Burleson, Thomas Aberant, Ashley K. Engemann, Bethany Henshall, Maurisa Darby, Christina Proch, Michelle Dellascio, Alyssa Pittman, Jacob Suminguit, Taewoong Choi, Cristina Gasparetto, Gwynn D. Long, Richard D. Lopez, Stefanie Sarantopoulos, Mitchell E. Horwitz, Nelson J. Chao, Anthony D. Sung
Publikováno v:
Transplantation and cellular therapy. 28(8)
Allogeneic hematopoietic stem cell transplantation (HCT) is a potentially curative treatment for both malignant and nonmalignant hematologic diseases; however, reported rates of treatment-related mortality approach 30%. Outcomes are worse in patients
Autor:
Patrick J, Smith, Meagan, Lew, Yen, Lowder, Kristi, Romero, Jillian C, Thompson, Lauren, Bohannon, Alyssa, Pittman, Alexandra, Artica, Sendhilnathan, Ramalingam, Taewoong, Choi, Cristina, Gasparetto, Mitchell, Horwitz, Gwynn, Long, Richard, Lopez, David, Rizzieri, Stefanie, Sarantopoulos, Keith, Sullivan, Nelson, Chao, Anthony D, Sung
Publikováno v:
Bone marrow transplantation. 57(1)
Hematopoietic cell transplant (HCT) is an increasingly common and curative treatment strategy to improve survival among individuals with malignant and nonmalignant diseases, with over one million HCTs having been performed worldwide. Neurocognitive d
Autor:
Patrick Smith, Lauren Bohannen, Jill Thompson, Yen P. Lowder, Nelson J. Chao, Meagan Lew, Alyssa Pittman, Kristi Romero, Cristina Gasparetto, Mitchell E. Horwitz, Anthony D. Sung, David A. Rizzieri, Taewoong Choi, Keith M. Sullivan, Stefanie Sarantopoulos, Richard D. Lopez, Gwynn D. Long
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S241
Background Hematopoietic cell transplant (HCT) is an increasingly common and curative treatment strategy to improve survival among individuals malignant and nonmalignant diseases, with over one million HCTs having been performed worldwide. Neurocogni
Autor:
Cristina Gasparetto, Meagan V. Lew, Katherine S. Hall, Pao-Hwa Lin, Tanya Helms, Margaret Eren, Whitney Andrew, Renee Welch, Glynnis Thorpe, Stefanie Sarantopoulos, Ashley K. Engemann, Patrick Smith, Sophia K. Smith, Michelle Dellascio, Yen P. Lowder, Richard D. Lopez, Jillian C. Thompson, Anthony D. Sung, Thomas Aberant, Taewoong Choi, Sarah A. Kelleher, David A. Rizzieri, Harvey J. Cohen, Maurisa Darby, Brittany Matthews, Renea Valea, JoAnn Liu, Alyssa Pittman, Whitney Hicks, Tamara J. Somers, Therese Hennig, Kristi Romero, Yi Ren, David A. Bartlett, Amy M. Pastva, Bethany Henshall, Katherine B. Peters, Paul E. Wischmeyer, Rebecca Porter, Kristi Wiggins, Nelson J. Chao, Allison Adler, Miriam C. Morey, Mitchell E. Horwitz, Christina Proch, Lauren Bohannon, Kerry King Minor, Jill Burleson, Gwynn D. Long
Publikováno v:
Blood. 134:1984-1984
Introduction: Geriatric assessment (GA) is a multidimensional evaluation of patient health and function that may detect impairments not identified as part of routine care, predict treatment-related morbidity and mortality, and inform treatment plans.